Mingyuan Wu

机构：Fudan University, Shanghai University of Traditional Chinese Medicine, Zhongshan Hospital, Shanghai Traditional Chinese Medicine Hospital · ORCID：0000-0001-8367-3478

发表论文 148 篇 · 总被引 4886 次 · h-index 34

代表论文

• Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity (2024 · Cell Reports Medicine · 被引 32)
• The sphingolipids change in exosomes from cancer patients and association between exosome release and sphingolipids level based on a pseudotargeted lipidomics method (2024 · Analytica Chimica Acta · 被引 19)
• The nanobody targeting PD-L1 and CXCR4 counteracts pancreatic stellate cell-mediated tumour progression by disrupting tumour microenvironment (2024 · International Immunopharmacology · 被引 13)
• Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering (2025 · Proceedings of the National Academy of Sciences · 被引 11)
• Characterization of a novel T cell-engaging bispecific antibody for elimination of L1CAM-positive tumors (2024 · Biomedicine & Pharmacotherapy · 被引 9)
• Long-term passaging of pseudo-typed SARS-CoV-2 reveals the breadth of monoclonal and bispecific antibody cocktails (2023 · Acta Pharmacologica Sinica · 被引 8)